Clinical Trial Update: Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the safety and efficacy of adding telaprevir to peginterferon alfa-2a and ribavirin in people co-infected with hepatitis C and HIV.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2013-10-10